In this study we used a comprehensive tagSNP approach to evaluate associations with breast cancer risk and survival, taking into account genetic admixture, menopausal status, estrogen receptor (ER) and progesterone receptor (PR) tumor status, tumor grade, and disease stage. This evidence concerns the gene ESR1 and neoplasm.